Post by Incyte on X
Incyte@Incyte
XWe’ve announced positive topline results from the Phase 3 frontMIND trial in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). Read our press release to learn more. t.co
7 likes0 repliesPosted Jan 5, 2026